Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its validated chemistry and drug discovery expertise to provide novelty to its customers with exclusive or non-exclusive small molecules and with efficient hit-to-lead optimization capabilities.
Browse our website or contact us for further information
2014-09-07 / 2014-09-11
Edelris will be attending the EFMC-ISMC 2014 in Lisbon, Portugal. Meet us at Booth #6!
2014-07-02 / 2014-07-04
Edelris will be attending the RICT 2014 in Rouen, France.